New York – July 8, 2026 – Cooley advised Pearl Health, a healthcare technology company helping manage risk and deliver better care to Medicare patients, on its $110 million capital raise, comprised of a $50 million equity investment led by Andreessen Horowitz with participation from Viking Global Investors, AlleyCorp and Ulysses Capital, and a $60 million debt facility led by Trinity Capital.

The new capital will expand Pearl's AI platform, turning clinical intelligence into measurable outcomes, and accelerate its growth across enterprise health system and payer partnerships, its expansion into Medicare Advantage, and new risk offerings.

Lawyers Roy Moran, Greg Reith, Alexis Finkelberg Bortniker, Xiaoyu Huang, Michael Bruno and Mariam Kamal led the Cooley team advising Pearl Health.

Cooley previously advised Pearl Health on its $75 million oversubscribed Series B in January 2023.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.